Changsheng Ma

13.4k total citations · 2 hit papers
460 papers, 6.7k citations indexed

About

Changsheng Ma is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Changsheng Ma has authored 460 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 352 papers in Cardiology and Cardiovascular Medicine, 68 papers in Surgery and 36 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Changsheng Ma's work include Atrial Fibrillation Management and Outcomes (218 papers), Cardiac Arrhythmias and Treatments (172 papers) and Cardiac electrophysiology and arrhythmias (79 papers). Changsheng Ma is often cited by papers focused on Atrial Fibrillation Management and Outcomes (218 papers), Cardiac Arrhythmias and Treatments (172 papers) and Cardiac electrophysiology and arrhythmias (79 papers). Changsheng Ma collaborates with scholars based in China, United States and United Kingdom. Changsheng Ma's co-authors include Jianzeng Dong, Ribo Tang, Xin Du, Deyong Long, Ronghui Yu, Caihua Sang, Rong Bai, Nian Liu, Xin Du and Songnan Li and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Changsheng Ma

421 papers receiving 6.5k citations

Hit Papers

The Increasing Role of Rhythm Control in Patients With At... 2022 2026 2023 2024 2022 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changsheng Ma China 39 4.5k 971 602 569 561 460 6.7k
Krzysztof J. Filipiak‬ Poland 37 3.0k 0.7× 1.3k 1.3× 447 0.7× 958 1.7× 552 1.0× 502 6.0k
Panagiotis Korantzopoulos Greece 37 3.4k 0.7× 641 0.7× 370 0.6× 618 1.1× 326 0.6× 202 4.8k
Bryan P. Yan Hong Kong 39 3.0k 0.7× 1.4k 1.4× 304 0.5× 646 1.1× 230 0.4× 208 5.0k
Guangping Li China 40 3.1k 0.7× 803 0.8× 531 0.9× 1.5k 2.7× 225 0.4× 329 5.9k
Jianzeng Dong China 35 3.6k 0.8× 681 0.7× 177 0.3× 713 1.3× 280 0.5× 442 5.5k
Myeong‐Chan Cho South Korea 40 4.4k 1.0× 1.7k 1.8× 466 0.8× 652 1.1× 149 0.3× 329 6.2k
Chung‐Wah Siu Hong Kong 51 4.6k 1.0× 1.9k 1.9× 572 1.0× 2.5k 4.4× 499 0.9× 279 8.9k
Darryl P. Leong Canada 40 3.3k 0.7× 841 0.9× 314 0.5× 473 0.8× 124 0.2× 181 5.6k
Dong‐Ju Choi South Korea 41 4.3k 0.9× 1.7k 1.8× 467 0.8× 642 1.1× 158 0.3× 345 6.6k
Paolo Calabrò Italy 45 3.6k 0.8× 1.6k 1.7× 953 1.6× 1.3k 2.2× 349 0.6× 298 7.4k

Countries citing papers authored by Changsheng Ma

Since Specialization
Citations

This map shows the geographic impact of Changsheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsheng Ma more than expected).

Fields of papers citing papers by Changsheng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changsheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsheng Ma. The network helps show where Changsheng Ma may publish in the future.

Co-authorship network of co-authors of Changsheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Changsheng Ma. A scholar is included among the top collaborators of Changsheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changsheng Ma. Changsheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Xu, Hui Xu, Chao Jiang, et al.. (2025). Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome. Journal of Cardiovascular Electrophysiology. 36(11). 2910–2918.
5.
Ma, Changsheng, et al.. (2024). Neurotoxicity from long-term exposure to 6-PPDQ: Recent advances. Ecotoxicology and Environmental Safety. 282. 116689–116689. 14 indexed citations
6.
Guo, Lizhu, Xin Du, Shijun Xia, et al.. (2024). Factors associated with patients’ healthcare-seeking behavior and related clinical outcomes under China’s hierarchical healthcare delivery system. Frontiers in Public Health. 12. 1326272–1326272. 5 indexed citations
7.
Wang, Zhiyan, Yiqun Zhang, Rong Hu, et al.. (2024). Atrial Fibrillation Follow-up Investigation to Recover Memory and Learning Trial (AFFIRMING): Rationale and Design of a Multi-center, Double-blind, Randomized Controlled Trial. SHILAP Revista de lepidopterología. 9(1). 1 indexed citations
8.
Ma, Changsheng, et al.. (2024). Chinese guidelines for the diagnosis and management of atrial fibrillation. Pacing and Clinical Electrophysiology. 47(6). 714–770. 10 indexed citations
9.
Jiang, Jie, Fangfang Fan, Jing Zhou, et al.. (2024). Prevalence, Characteristics, and Treatment Strategy of Different Types of Heart Failure in Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association. 13(19). e033941–e033941.
10.
Lai, Yiwei, Mingyang Gao, Qifan Li, et al.. (2024). Characteristics of Right-Sided Accessory Pathways Associated With Right Cardiac Veins. Circulation Arrhythmia and Electrophysiology. 17(5). e012513–e012513.
12.
Du, Xin, Wenjie Li, Hao Zhang, et al.. (2023). The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial. Circulation. 148(7). 565–574. 28 indexed citations
13.
Ma, Changsheng, et al.. (2023). The value of myocardial work in patients with left ventricular hypertrophy. The International Journal of Cardiovascular Imaging. 39(6). 1105–1113. 4 indexed citations
14.
Wang, Xiao, Jingyao Fan, Wei Gong, et al.. (2023). Prognostic Implications of OSA in Acute Coronary Syndrome by Obesity Status. CHEST Journal. 164(1). 219–230. 13 indexed citations
15.
Li, Songnan, et al.. (2023). Atrial fibrillation catheter ablation associated silent cerebral emboli: A narrative review. Pacing and Clinical Electrophysiology. 46(9). 1124–1133. 5 indexed citations
16.
Lai, Yiwei, Qi Guo, Caihua Sang, et al.. (2022). Revisiting the characteristics and ablation strategy of biatrial tachycardias: a case series and systematic review. EP Europace. 25(3). 905–913. 11 indexed citations
17.
18.
Wang, Yue, Yuan Zhou, Lei Zhao, et al.. (2019). Relationship between coronary artery calcification and calcium deposition in the myocardium. Journal of International Medical Research. 47(7). 2910–2920. 1 indexed citations
19.
Chen, Xuan, Jianzeng Dong, Xin Du, et al.. (2018). Long‐term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy. Journal of Cardiovascular Electrophysiology. 29(7). 951–957. 11 indexed citations
20.
Wen, Songnan, Nian Liu, Songnan Li, et al.. (2015). [Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation].. PubMed. 43(7). 589–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026